GE Healthcare invests RMB 380 million to expand diagnostic pharmaceutical operations in Shanghai

GE Healthcare signed a letter of intent with the Pudong New District government to invest an additional RMB 380 million in its Shanghai diagnostic drug production base, covering new product introduction, new production lines, green upgrades, and digital transformation.

“On May 15, GE Healthcare announced the signing of a letter of intent for investment cooperation with the Science and Technology and Economy Committee of Pudong New District, Shanghai, to increase investment RMB 380 million RMB.”vcbeathealth.com

• 1 source
• vcbeathealth.comGE Healthcare Invests RMB 380 Million to Expand Diagnostic Pharmaceutical Operations in Shanghai-VCBeatMay 21, 2024

Summarized from public sources; check the original articles before acting on it.